natgillin/translations-raw huggingface dataset:
If you have persistent or longstanding, frequently recurring symptoms even after treatment with this medicine, you should contact your doctor. 
Če imate trdovratne ali dolgotrajne, pogosto ponavljajoče se simptome tudi še po zdravljenju s tem zdravilom, se morate posvetovati z zdravnikom.
However, the maximum levels of inhibition of (ADP induced) platelet aggregation in these subjects were the same in both groups. 
Največja raven zavrtja (z ADP inducirane) agregacije trombocitov pa je bila pri preiskovancih v obeh skupinah enaka.
• The recommended dose is one tablet a day. 
• Priporočeni odmerek je ena tableta na dan.
Patients over 55 years taking any non-prescription indigestion or heartburn remedy on a daily basis should inform their pharmacist or doctor. 
Bolniki, starejši od 55 let, ki vsak dan jemljejo brez recepta dostopna zdravila proti želodčnim težavam ali zgagi, morajo o tem obvestiti farmacevta ali zdravnika.
This increase is dose-dependent and results in a more than dose proportional increase in AUC after repeated administration. 
Povečanje je odvisno od odmerka in po večkratni uporabi povzroči več kot odmerku sorazmerno povečanje AUC.
No other liquids should be used as the enteric coating may be dissolved. 
Drugih tekočin se ne sme uporabljati, ker se lahko gastrorezistentna obloga raztopi.
Symptoms associated with acid reflux (such as heartburn and acid regurgitation) were evaluated retrospectively over a 24 hour period. 
Simptome, povezane z refluksom želodčne kisline (kot sta zgaga in regurgitacija kisline), so ocenjevali retrospektivno v 24-urnem obdobju.
To avoid this interference, Nexium Control treatment should be stopped for at least 5 days before CgA measurements (see section 5.1). 
Da bi to preprečili, je treba vsaj pet dni pred meritvami CgA prekiniti zdravljenje z zdravilom Nexium Control (glejte poglavje 5.1).
Do not use if you are allergic to esomeprazole or any of the other ingredients of this medicine. 
Ne jemljite zdravila, če ste alergični na esomeprazol ali katerokoli drugo sestavino tega zdravila.
• You have severe or persistent diarrhoea; esomeprazole has been associated with a small increased risk of infectious diarrhoea. 
• huda ali trdovratna driska; esomeprazol je povezan z nekoliko večjim tveganjem za infekcijsko drisko,
Esomeprazole has minor influence on the ability to drive or use machines. 
Esomeprazol ima manjši vpliv na sposobnost vožnje in upravljanja strojev.
It belongs to a group of medicines called ‘proton pump inhibitors'. 
Spada v skupino zdravil, ki jih imenujemo "zaviralci protonske črpalke".
If you notice any of the following serious side effects, stop taking Nexium Control and contact a doctor immediately: 
Če opazite katerega od naslednjih resnih neželenih učinkov, nehajte jemati zdravilo Nexium Control in se takoj posvetujte z zdravnikom:
Due to the similar pharmacodynamic effects and pharmacokinetic properties of omeprazole and esomeprazole, concomitant administration with esomeprazole and atazanavir is not recommended and concomitant administration with esomeprazole and nelfinavir is contraindicated (see section 4.3 and 4.4). 
Zaradi podobnih farmakodinamičnih učinkov in farmakokinetičnih značilnosti omeprazola in esomeprazola sočasna uporaba esomeprazola in atazanavirja ni priporočljiva, sočasna uporaba esomeprazola in nelfinavirja pa je kontraindicirana (glejte poglavji 4.3 in 4.4).
• The active substance is esomeprazole. 
• Učinkovina je esomeprazol.
If lesions occur, especially in sun-exposed areas of the skin, and if accompanied by arthralgia, the patient should seek medical help promptly and the health care professional should consider stopping Nexium Control. 
Če se pojavijo lezije, zlasti na koži, ki je izpostavljena soncu, in sočasna artralgija, mora bolnik takoj poiskati zdravniško pomoč, zdravstveni delavec pa mora razmisliti o prekinitvi zdravljenja z zdravilom Nexium Control.
However, patients with severe liver impairment should be advised by a doctor before taking Nexium Control (see sections 4.4 and 5.2). 
Bolnikom s hudo okvaro jeter pa je treba naročiti, naj se pred jemanjem zdravila Nexium Control posvetujejo z zdravnikom (glejte poglavji 4.4 in 5.2).
- If you are allergic to medicines containing other proton pump inhibitors (e.g. pantoprazole, 
- Če ste alergični na zdravila, ki vsebujejo druge zaviralce protonske črpalke (npr. pantoprazol,
Almost 80% of an oral dose of esomeprazole is excreted as metabolites in the urine, the remainder in the faeces. 
Skoraj 80 % peroralnega odmerka esomeprazola se izloči v obliki presnovkov v urinu, preostanek pa v blatu.
The median time to first resolution of night-time heartburn was 1 day, statistically significant compared to placebo in one study (p=0.048) and approaching significance in the other (p=0.069). 
Mediana časa do prvega prenehanja nočne zgage je bila en dan, kar je bilo v eni študiji statistično pomembno v primerjavi s placebom (p = 0,048) in skoraj statistično pomembno v drugi študiji (p = 0,069).
• The recommended dose is one capsule a day. 
• Priporočeni odmerek je ena kapsula na dan.
• Put the tablet in a glass of still (non-fizzy) water. 
• Tableto dajte v kozarec negazirane vode (vode brez mehurčkov).
Metabolism and nutrition disorders peripheral oedema hyponatraemia hypomagnesaemia; severe hypomagnesaemia can correlate with hypocalcaemia; hypomagnesaemia may also result in hypokalaemia 
Presnovne in prehranske motnje periferni edemi hiponatriemija hipomagneziemija, huda hipomagneziemija je lahko povezana s hipokalciemijo; hipomagneziemija lahko povzroči hipokaliemijo
Esomeprazole 20 mg should not be exceeded. 
Odmerek esomeprazola ne sme preseči 20 mg.
+K+-ATPase 
+K+-ATPazo (kislinsko črpalko).
This could be ‘Stevens-Johnson syndrome' or ‘toxic epidermal necrolysis', seen very rarely. 
To je lahko t. i. Stevens-Johnsonov sindrom ali toksična epidermalna nekroliza; pojavi se zelo redko.
Talk to your pharmacist or doctor if: 
Posvetujte se z zdravnikom ali farmacevtom, če:
Absorption of esomeprazole is rapid, with peak plasma levels occurring approximately 1-2 hours after dose. 
Absorpcija esomeprazola je hitra, najvišjo koncentracijo v plazmi pa doseže približno 1 do 2 uri po odmerku.
Corresponding proportions for esomeprazole 40 mg were 97%, 92% and 56%. 
Po 40 mg esomeprazola so bili ti deleži 97 %, 92 % in 56 %.
Combination with other medicinal products 
Kombinacija z drugimi zdravili
• To make sure that you have drunk all of the medicine, rinse the glass very well with half a glass of water and drink it. 
• Da boste popili zares vse zdravilo, kozarec nato zelo dobro splaknite s pol kozarca vode in to vodo popijte.
Nexium Control is not meant to bring immediate relief. 
Zdravilo Nexium Control ni namenjeno takojšnjemu olajšanju težav.
You may take this medicine with antacids (e.g. magaldrate, alginic acid, sodium bicarbonate, aluminium hydroxide, magnesium carbonate or combinations of these) if needed. 
To zdravilo lahko jemljete z antacidi (na primer z magaldratom, alginsko kislino, natrijevim bikarbonatom, aluminijevim hidroksidom, magnezijevim karbonatom ali njihovimi kombinacijami), če je to potrebno.
The apparent volume of distribution at steady state in healthy subjects is approximately 0.22 l/kg body weight. 
Navidezni volumen porazdelitve v stanju dinamičnega ravnovesja je pri zdravih preiskovancih približno 0,22 l/kg telesne mase.
Tell your doctor or pharmacist if you are taking any of the following medicines: 
Zdravniku ali farmacevtu morate povedati, če jemljete katero od naslednjih zdravil:
Esomeprazole should not be used during breast-feeding. 
Esomeprazola se med obdobjem dojenja ne sme uporabljati.
• You have ever had a skin reaction after treatment with a medicine similar to Nexium Control that reduces stomach acid. 
• ste že kdaj imeli kožno reakcijo po zdravljenju z zdravilom, podobnim zdravilu Nexium
Patients should consult their doctor before taking this medicinal product if they are due to have an endoscopy or urea breath test. 
Pred jemanjem tega zdravila naj se bolniki posvetujejo z zdravnikom, če imajo predvideno endoskopijo ali dihalni test s sečnino.
Esomeprazole is 97% plasma protein bound. 
Esomeprazol se v 97 % veže na beljakovine v plazmi.
Esomeprazole is completely metabolised by the cytochrome P450 system (CYP). 
Esomeprazol se povsem presnovi s sistemom citokroma P450 (CYP).
• Do not take more than this recommended dose of one tablet (20 mg) a day, even if you don't feel an improvement immediately. 
• Ne vzemite večjega odmerka od priporočenega, ki je ena tableta (20 mg) na dan, tudi če ne čutite takoj izboljšanja.
Gastro-resistant tablet. 
Gastrorezistentna tableta.
Esomeprazole is the S-isomer of omeprazole and reduces gastric acid secretion through a specific targeted mechanism of action. 
Esomeprazol je S-izomer omeprazola in zmanjša izločanje želodčne kisline prek specifičnega mehanizma delovanja.
It is important not to damage the pellets. 
Pomembno je, da se zrnca ne poškodujejo.
Pharmacotherapeutic group: Drugs for acid related disorders, proton pump inhibitors, ATC code: A02BC05. 
Farmakoterapevtska skupina: zdravila za kislinsko pogojene bolezni, zaviralci protonske črpalke, oznaka ATC: A02BC05.
The slightly prolonged QTc interval observed after administration of cisapride alone, was not further prolonged when cisapride was given in combination with esomeprazole. 
Rahlo podaljšanje intervala QTc, opaženo po uporabi samega cisaprida, se med sočasno uporabo cisaprida in esomeprazola ni dodatno povečalo.
• You get a rash on your skin, especially in areas exposed to the sun tell your doctor as soon as you can, as you may need to stop your treatment with Nexium Control. 
• če se pojavi kožni izpuščaj, zlasti na koži, ki je izpostavljena soncu, čim prej obvestite zdravnika, saj boste morda morali prekiniti zdravljenje z zdravilom Nexium Control.
Your doctor may need to monitor you when you start or stop taking Nexium Control. 
Zdravnik vas bo morda moral spremljati, ko boste začeli ali nehali jemati zdravilo Nexium Control.
The capsule has a yellow centre band, and contains yellow and purple enteric coated pellets. 
Kapsula ima rumeno sredinsko črto in vsebuje rumena in vijolična zrnca z gastrorezistentno oblogo.
Elderly patients (≥65 years old) Dose adjustment is not required in elderly patients. 
Starejši bolniki (stari 65 let ali več) Starejšim bolnikom odmerka ni treba prilagoditi.
Esomeprazole is extensively plasma protein bound and is therefore not readily dialysable. 
Esomeprazol se v veliki meri vezže na beljakovine v plazmi in se zato ne dializira zlahka.
• If you are allergic to esomeprazole or any of the other ingredients of this medicine (listed in section 6). 
- Če ste alergični na esomeprazol ali katerokoli sestavino tega zdravila (navedeno v poglavju 6).
• Do not take more than this recommended dose of one capsule (20 mg) a day, even if you don't feel an improvement immediately. 
• Ne vzemite večjega odmerka od priporočenega, ki je ena kapsula (20 mg) na dan, tudi če ne čutite takoj izboljšanja.
Alternative method of taking this medicine 
Drugi možni način jemanja tega zdravila
The parameters below reflect mainly the pharmacokinetics in individuals with a functional CYP2C19 enzyme, extensive metabolisers. 
Spodaj navedeni parametri odražajo predvsem farmakokinetiko pri posameznikih s funkcionalnim encimom CYP2C19, tj. dobrih metabolizatorjih.
Total plasma clearance is about 17 l/h after a single dose and about 9 l/h after repeated administration. 
Celotni plazemski očistek je približno 17 l/h po posamičnem odmerku in približno 9 l/h po večkratni uporabi.
These findings have no implications for the posology of esomeprazole. 
Ti izsledki ne vplivajo na odmerjanje esomeprazola.
• If you are suffering from any of the side effects detailed in Section 4 which require medical attention. 
• če imate katerekoli neželene učinke, opisane v poglavju 4, zaradi katerih morate poiskati zdravniško pomoč.
In healthy volunteers, concomitant administration of 40 mg esomeprazole resulted in a 32% increase in area under the plasma concentration-time curve (AUC) and a 31% prolongation of elimination half-life(t1/2) but no significant increase in peak plasma levels of cisapride. 
Pri zdravih prostovoljcih je sočasna uporaba 40 mg esomeprazola povzročila 32 % povečanje površine pod krivuljo plazemske koncentracije po času (AUC) in 31 % podaljšanje eliminacijskega razpolovnega časa (t1/2), a brez pomembnega povečanja največje koncentracije cisaprida v plazmi.
Psychiatric disorders insomnia agitation, confusion, depression aggression, hallucinations 
Psihiatrične motnje nespečnost agitiranost, zmedenost, depresija agresivnost, halucinacije
• Aggression 
• napadalnost
If affected, patients should not drive or use machines. 
Bolniki, pri katerih se pojavijo ti neželeni učinki, ne smejo voziti ali upravljati strojev.
• If you experience any of the symptoms detailed in Section 2 of this leaflet and it advises you to talk to your doctor or pharmacist. 
• če se pojavijo katerikoli simptomi, opisani v poglavju 2 teh navodil za uporabo, in je navedeno, da se posvetujte z zdravnikom ali farmacevtom;
Do not take this medicine with other medicines that limit the amount of acid produced in your stomach such as proton pump inhibitors (e.g. pantoprazole, lansoprazole, rabeprazole or omeprazole) or an H2 antagonist (e.g. ranitidine or famotidine). 
Ne jemljite tega zdravila z drugimi zdravili, ki zmanjšujejo nastajanje kisline v želodcu, npr. z zaviralcem protonske črpalke (na primer s pantoprazolom, lansoprazolom, rabeprazolom ali omeprazolom) ali antagonistom receptorjev H2 (na primer z ranitidinom, famotidinom).
Thus, when esomeprazole is combined with medicinal products metabolised by CYP2C19, such as warfarin, phenytoin, citalopram, imipramine, clomipramine, diazepam, etc., the plasma concentrations of these medicinal products may be increased and a dose reduction could be needed. 
Če je torej esomeprazol uporabljen v kombinaciji z zdravili, ki se presnavljajo s CYP2C19, npr. z varfarinom, fenitoinom, citalopramom, imipraminom, klomipraminom, diazepamom itn., se lahko koncentracija teh zdravil v plazmi zviša in potrebno je lahko zmanjšanje odmerka.
lansoprazole, rabeprazole or omeprazole). 
lansoprazol, rabeprazol ali omeprazol).
• Low numbers of red blood cells, white blood cells, and platelets (a condition called pancytopenia). 
• majhno število rdečih krvnih celic, belih krvnih celic in krvnih ploščic (takšno stanje imenujemo pancitopenija)
• You are taking any medicines listed in the package leaflet. 
• jemljete katerakoli zdravila, ki so navedena v navodilu za uporabo;
The absorption of medicinal products taken orally such as ketoconazole, itraconazole and erlotinib can decrease during treatment with esomeprazole and the absorption of digoxin can increase during treatment with esomeprazole. 
Absorpcija peroralnih zdravil, kot so ketokonazol, itrakonazol in erlotinib, se lahko med zdravljenjem z esomeprazolom zmanjša, absorpcija digoksina pa se lahko med zdravljenjem z esomeprazolom poveča.
In two multicentre, randomised, double-blind, placebo-controlled pivotal studies 234 subjects with a recent history of frequent heartburn were treated with 20 mg esomeprazole for 4 weeks. 
V dveh multicentričnih, randomiziranih, dvojno slepih, s placebom kontroliranih ključnih študijah je 234 preiskovancev z nedavno anamnezo pogoste zgage 4 tedne prejemalo 20 mg esomeprazola.
dry mouth stomatitis, gastrointestinal candidiasis microscopic colitis 
suha usta stomatitis, gastrointestinalna kandidoza mikroskopski kolitis
Patients with long-term recurrent symptoms of indigestion or heartburn should see their doctor at regular intervals. 
Bolniki, ki imajo dolgotrajne ponavljajoče se simptome težav z želodcem ali zgago, morajo hoditi na redne preglede k zdravniku.
For 20 mg esomeprazole the corresponding values are 50% and 68% respectively. 
Za 20-mg odmerek esomeprazola sta ti vrednosti 50 % oz. 68 %.
The bottle also contains a sealed container with silica gel desiccant. 
Plastenka vsebuje tudi zapečaten vsebnik s sušilom iz silikagela.
This medicinal product contains sugar spheres (sucrose). 
To zdravilo vsebuje sladkorne kroglice (saharozo).
The remaining part is dependent on another specific isoform, CYP3A4, responsible for the formation of esomeprazole sulphone, the main metabolite in plasma. 
Preostali del je odvisen od druge specifične izooblike, CYP3A4; CYP3A4 je odgovoren za tvorbo esomeprazolsulfona, glavnega presnovka esomeprazola v plazmi.
• You are due to have an endoscopy or a urea breath test. 
• ste naročeni na endoskopijo ali dihalni test s sečnino,
This time and dose-dependency is due to a decrease of first pass metabolism and systemic clearance probably caused by an inhibition of the CYP2C19 enzyme by esomeprazole and/or its sulphone metabolite. 
Ta odvisnost od časa in odmerka je posledica manjše presnove prvega prehoda in sistemskega očistka esomeprazola; vzrok je verjetno zavrtje encima CYP2C19 z esomeprazolom in/ali njegovim sulfonskim presnovkom.
Keep the container tightly closed to protect from moisture. 
Vsebnik shranjujte tesno zaprt za zagotovitev zaščite pred vlago.
If you take more Nexium Control than you should If you take more Nexium Control than recommended, talk to your doctor or pharmacist straight away. 
Če ste vzeli večji odmerek zdravila Nexium Control, kot je priporočeno, se takoj posvetujte z zdravnikom ali farmacevtom.
Other secondary endpoints were supportive of the primary endpoint, including relief of heartburn at week 1 and week 2, percentage of 24 hour days without heartburn at week 1 and week 2, mean heartburn severity at week 1 and week 2, and time to initial and sustained resolution of heartburn over a 24 hour period and during the night compared to placebo. 
Drugi sekundarni opazovani dogodki študije so podprli primarnega, vključno z olajšanjem zgage po enem in dveh tednih, odstotkom 24-urnih dni brez zgage po enem in dveh tednih, povprečno vrednostjo resnosti zgage po enem in dveh tednih ter časom do prvotnega in trajnega prenehanja zgage v 24-urnem obdobju in ponoči v primerjavi s placebom.
Concomitant treatment with omeprazole (20 mg daily) and digoxin in healthy subjects increased the bioavailability of digoxin by 10% (up to 30% in two out of ten subjects). 
Sočasno zdravljenje z omeprazolom (20 mg na dan) in digoksinom je pri zdravih preiskovancih povečalo biološko uporabnost digoksina za 10 % (do 30 % pri dveh od desetih preiskovancev).
Excipient(s) with known effect Each gastro-resistant hard capsule contains 11.5 mg sucrose. 
Pomožne snovi z znanim učinkom: Ena trda gastrorezistentna kapsula vsebuje 11,5 mg saharoze.
Do not take this medicine if you are also taking a medicine containing nelfinavir (used to treat HIV infection). 
Ne jemljite tega zdravila, če sočasno jemljete zdravilo, ki vsebuje nelfinavir (uporablja se za zdravljenje okužbe s HIV).
In vivo conversion to the R-isomer is negligible. 
Njegova pretvorba v R-izomer je in vivo zanemarljiva.
• Disturbed sleep (insomnia), feeling sleepy. 
• moten spanec (nespečnost), zaspanost
Food intake both delays and decreases the absorption of esomeprazole although this has no significant influence on the effect of esomeprazole on intragastric acidity. 
Uživanje hrane upočasni in zmanjša absorpcijo esomeprazola, vendar to bistveno ne vpliva na učinek zdravila na kislost v želodcu.
No dose-related adverse reactions have been identified. 
Z odmerkom povezanih neželenih učinkov niso ugotovili.
Using AUC as a surrogate parameter for plasma concentration, a relationship between inhibition of acid secretion and exposure has been shown. 
Z uporabo AUC kot nadomestnega parametra za koncentracijo v plazmi so ugotovili, da sta zavrtje izločanja kisline in izpostavljenosti zdravilu povezana.
There is very limited experience to date with deliberate overdose. 
Izkušnje z namernim prevelikim odmerjanjem zdravila so zelo omejene.
The symptoms described in connection with 280 mg esomeprazole were gastrointestinal symptoms and weakness. 
Pri odmerku 280 mg esomeprazola so bili opisani gastrointestinalni simptomi in šibkost.
• You have had a stomach ulcer or stomach surgery in the past. 
• ste v preteklosti kdaj imeli razjedo na želodcu ali operacijo želodca,
Reflux is the backflow of acid from the stomach into the gullet (“foodpipe”) which may become inflamed and painful. 
"Refluks" pomeni vračanje kisline iz želodca nazaj v požiralnik, ki se zaradi tega lahko vname in boli.
After oral dosing with esomeprazole 20 mg and 40 mg the onset of effect occurs within one hour. 
Po peroralni uporabi 20 mg ali 40 mg esomeprazola se učinek pojavi v eni uri.
Indigo carmine (E132) Erythrosine (E127) Allura red AC (E129) 
Ovojnica kapsule želatina indigo karmin (E132) eritrozin (E127) alura rdeče AC (E129)
You may experience symptoms such as diarrhoea, stomach ache, constipation, feeling or being sick and weakness. 
Pojavijo se lahko simptomi kot so driska, bolečine v želodcu, zaprtost, siljenje na bruhanje ali bruhanje in šibkost.
The investigators' assessments of heartburn resolution were consistent with the subjects' assessments, showing statistically significant differences between esomeprazole (34.7% - 41.8%) compared to placebo (8.0% - 11.4%). 
Ocene prenehanja zgage, ki so jih podali raziskovalci, so se ujemale z ocenami preiskovancev, kar kaže na statistično pomembne razlike med esomeprazolom (34,7-41,8 %) in placebom (8,0-11,4 %).
• Low levels of sodium in the blood. 
• nizka koncentracija natrija v krvi.
The major part of the metabolism of esomeprazole is dependent on the polymorphic CYP2C19, responsible for the formation of the hydroxy- and desmethyl metabolites of esomeprazole. 
Glavni del presnove esomeprazola je odvisen od polimorfizma CYP2C19, ki je odgovoren za tvorbo hidroksi- in demetiliranih presnovkov esomeprazola.
• Blood problems such as a reduced number of white blood cells or platelets. 
• krvne motnje, npr. zmanjšanje števila belih krvnih celic (levkocitov) ali krvnih ploščic
Effects of esomeprazole on the pharmacokinetics of other medicinal products As esomeprazole is one enantiomer of omeprazole it is reasonable to advise about interactions reported with omeprazole. 
Učinki esomeprazola na farmakokinetiko drugih zdravil Esomeprazol je enantiomer omeprazola, zato je upravičeno opozoriti na medsebojna delovanja, opisana pri omeprazolu.
When starting or ending treatment with esomeprazole, the potential for interactions with medicinal products metabolised through CYP2C19 should be considered. 
Na začetku in na koncu zdravljenja z esomeprazolom je treba upoštevati možnost medsebojnega delovanja z zdravili, ki se presnavljajo s CYP2C19.
• You have jaundice (yellowing of skin or eyes) or severe liver problems. 
• imate zlatenico (porumenelost kože ali očesnih beločnic) ali hudo okvaro jeter,
Other possible interaction mechanisms are via inhibition of CYP2C19. 
Drugi možni mehanizmi medsebojnega delovanja so prek zavrtja CYP2C19.
Nexium Control contains sugar spheres, which contain sucrose, a type of sugar. 
Zdravilo Nexium Control vsebuje sladkorne kroglice, ki vsebujejo saharozo (vrsta sladkorja).
If the combination of atazanavir with a PPI is judged unavoidable, close clinical monitoring is recommended in combination with an increase in the dose of atazanavir to 400 mg with 100 mg of ritonavir. 
Če se sočasni uporabi atazanavirja in zaviralca protonske črpalke ni mogoče izogniti, sta priporočljiva natančen klinični nadzor ter povečanje odmerka atazanavirja na 400 mg s 100 mg ritonavirja.
Investigated medicinal products with no clinically relevant interaction Amoxicillin and quinidine 
Preiskovana zdravila brez klinično pomembnih interakcij Amoksicilin in kinidin
The absolute bioavailability is 64% after a single dose of 40 mg and increases to 89% after repeated once-daily administration. 
Absolutna biološka uporabnost po posamičnem 40-mg odmerku je 64 %, po večkratnem odmerjanju enkrat na dan pa se poveča na 89 %.
• Cilostazol (used to treat intermittent claudication - a condition where poor blood supply to the leg muscles causes pain and difficulty in walking) 
• cilostazol (uporablja se za zdravljenje intermitentne klavdikacije - stanje, kjer nezadosten dotok krvi v mišice nog povzroči bolečine in težave pri hoji)